Table 5 Adverse events in the dose escalation study
Adverse event | Subjects (%) |
|---|---|
Total subjects with any event | 24 (69) |
Subjects with a serious adverse event | 0 (0) |
Total adverse events | 57 (100) |
Study related | 14 (25) |
 IV placement difficulties | 1 (1.8) |
 IV infiltration | 1 (1.8) |
 Phlebitis | 1 (1.8) |
 Skin reaction to tape | 1 (1.8) |
 Extremity erythema due to BP cuff | 1 (1.8) |
 Vasovagal episode with IV placement | 1 (1.8) |
 Incorrect stable isotope administered | 1 (1.8) |
 Nausea | 3 (5) |
 Anemia | 4 (7) |
Not study related | 43 (75) |
 Infectious | 15 (26) |
 Allergy/immunology | 3 (5) |
 Musculoskeletal | 8 (14) |
 CNS | 3 (5) |
 Psychiatric | 5 (9) |
 Cardiovascular | 2 (4) |
 GI | 4 (7) |
 Metabolic | 3 (5) |